Advanced Knee Structure Analysis (AKSA): a comparison of bone mineral density and trabecular texture measurements using computed tomography and high-resolution peripheral quantitative computed tomography of human knee cadavers

Abstract

BackgroundA change of loading conditions in the knee causes changes in the subchondral bone and may be a cause of osteoarthritis (OA). However, quantification of trabecular architecture in vivo is difficult due to the limiting spatial resolution of the imaging equipment; one approach is the use of texture parameters. In previous studies, we have used digital models to simulate changes of subchondral bone architecture under OA progression. One major result was that, using computed tomography (CT) images, subchondral bone mineral density (BMD) in combination with anisotropy and global homogeneity could characterize this progression.The primary goal of this study was a comparison of BMD, entropy, anisotropy, variogram slope, and local and global inhomogeneity measurements between high-resolution peripheral quantitative CT (HR-pQCT) and CT using human cadaveric knees. The secondary goal was the verification of the spatial resolution dependence of texture parameters observed in the earlier simulations, two important prerequisites for the interpretation of in vivo measurements in OA patients.MethodThe applicability of texture analysis to characterize bone architecture in clinical CT examinations was investigated and compared to results obtained from HR-pQCT. Fifty-seven human knee cadavers (OA status unknown) were examined with both imaging modalities. Three-dimensional (3D) segmentation and registration processes, together with automatic positioning of 3D analysis volumes of interest (VOIs), ensured the measurement of BMD and texture parameters at the same anatomical locations in CT and HR-pQCT datasets.ResultsAccording to the calculation of dice ratios (>0.978), the accuracy of VOI locations between methods was excellent. Entropy, anisotropy, and global inhomogeneity showed significant and high linear correlation between both methods (0.68 < R 2 < 1.00). The resolution dependence of these parameters simulated earlier was confirmed by the in vitro measurements.ConclusionThe high correlation of HR-pQCT- and CT-based measurements of entropy, global inhomogeneity, and anisotropy suggests interchangeability between devices regarding the quantification of texture. The agreement of the experimentally determined resolution dependence of global inhomogeneity and anisotropy with earlier simulations is an important milestone towards their use to quantify subchondral bone structure. However, an in vivo study is still required to establish their clinical relevance.

Secukinumab: A Review in Ankylosing Spondylitis

“…Secukinumab was also associated with significant improvements in all secondary endpoints, with the exception of ASAS partial remission rates in MEASURE 2 and 3 (Table 2) [13, 14]. In MEASURE 4, secukinumab (with or without a loading dose) was not superior to placebo at week 16 for the primary endpoint or for any of the secondary endpoints (Table 2) [15].…”

“…In MEASURE 3, the EAIR of grade 3/4 neutropenia with secukinumab 150 mg during the 52-week safety-data period was 0.9/1.8 per 100 PY [14]. In MEASURE 4, the EAIR of neutropenia with secukinumab 150 mg was 0.5 per 100 PY when administered with a loading dose and 0.0 per 100 PY when administered without a loading dose [15].…”

Risk factors and association of body composition components for lumbar disc herniation in Northwest, Mexico

“…From structural damages, we can find those of Modic change (pathological changes in the vertebral body) 17 . Risk of damage is mainly present in people with android obesity, while a protection factor for sever damage is present in people with gynoid obesity 18 , 19 . Besides the distribution of the body adiposity can play a more important role in triggering lumbar disc herniation 20 .…”

Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome

“…Whether pIRAK-4 may also serve as a marker for anakinra responsiveness in RA patients remains to be defined. Other phosphorylated signaling molecules, such as JAK2 and 3, STAT1, 3, and 6 in different leukocyte subsets, have been examined as markers of treatment response in smaller RA collectives by ( 20 – 22 ). However, trials to establish IRAK-4 inhibitors as a new therapy in rheumatoid arthritis are underway ( 23 ), which underlines the possible value of this target.…”